Celgene Corp (CELG)

CELG (NASDAQ:Drugs) EQUITY
$104.53
pos +1.76
+1.71%
Today's Range: 102.70 - 105.24 | CELG Avg Daily Volume: 4,154,300
Last Update: 09/30/16 - 4:14 PM EDT
Volume: 4,644,592
YTD Performance: -14.19%
Open: $103.42
Previous Close: $102.77
52 Week Range: $92.98 - $137.54
Oustanding Shares: 775,114,702
Market Cap: 82,030,388,913
6-Month Chart
TheStreet Ratings Grade for CELG
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 14 14 14 13
Moderate Buy 0 0 0 1
Hold 3 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.35 1.35 1.35 1.41
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 44.47
Price Earnings Comparisons:
CELG Sector Avg. S&P 500
44.47 51.40 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
4.01% -2.44% 32.94%
GROWTH 12 Mo 3 Yr CAGR
Revenue 20.70 0.70 0.19
Net Income -19.90 0.10 0.03
EPS -18.80 0.20 0.06
Earnings for CELG:
EBITDA 2.96B
Revenue 9.26B
Average Earnings Estimates
Qtr (09/16) Qtr (12/16) FY (12/16) FY (12/17)
Average Estimate $1.31 $1.36 $5.11 $6.43
Number of Analysts 9 9 9 4
High Estimate $1.33 $1.41 $5.17 $6.66
Low Estimate $1.29 $1.32 $5.04 $6.21
Prior Year $1.12 $1.00 $4.08 $5.11
Growth Rate (Year over Year) 16.67% 36.44% 25.14% 25.89%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
RMPIA
By

Bret Jensen

 | Sep 29, 2016 | 10:00 AM EDT
BioDelivery Sciences, Progenics Pharma and Sequential Brands are off-the-radar small-caps poised for a big year in 2017.
RMPIA
By

Doug Kass

 | Sep 28, 2016 | 5:29 PM EDT
The U.S. dollar flat-lined. The price of crude oil increased by $2 a barrel to $46.67 on the OPEC chatter, previously mentioned. Gold fell by $4.60 to $1,325 ... not trading well. Agricultural commodities mostly lower: wheat was down $0.02, corn down $0.02, soybeans down $0.07 and oats down $0.01. Lumber up $1. Bonds were unchanged, with little movement in yields. The 10-year yield was up 1, and the long bond was flat. 2s/10s (yield curve) flat at 81 basis points. Municipals flat, but junk bond prices ripped after OPEC and closed much higher on the day. Blackstone/GSO Strategic Credit Fund (BGB) rose $0.13 to nearly $15. I would sell this strength. Banks rallied despite the lousy publicity: Congressional uproar and California state's temporary cancellation of its business relationship with Wells Fargo. More in my opening missive. The canary in the coal mine, DB, rallied after weeks of weakness. My view? Neidermeyer, dead. Deutsch Bank (DB) dead.  REITs fell small, after broad gains in the last few days. I added to my iShares Dow Jones US Real Estate ETF (IYR) short. Insurance and brokerages rallied -- albeit modestly. Staying long HIG and short Morgan Stanley (MS) , Goldman Sachs (GS) , Metlife (MET) and Lincoln National (LNC) . Biotech under-performed. Allergan (AGN) , Gilead Sciences (
RMPIA
By

Doug Kass

 | Sep 26, 2016 | 5:45 PM EDT
Why I sold Twitter on Friday. Why upside/downside targets are my investing religion.  Why it would be Goofy for Disney (DIS) to buy Twitter. Remember media companies, unlike Google and Salesforce, are bounded by EPS and cash flow. Disney has its own problems. I remain short.  A contrary view: Don't bank on the banks. As I mentioned (and added to my aforementioned thesis to avoid financials) to Jimmy Cramer in an email late this afternoon:   Jim, It is clear the Fed WANTS to raise in December. It is also clear that the rate of growth in domestic economy is slowing. If the Fed raises and the economy remains moribund, we risk a flatter curve rather than a steeper curve -- which is bad for banks and goes against the meme that a rate rise will help improve NIM and lead to improved valuations.   Fertilizer stocks trade like crap. Stay away. I am.   Damn, Chipotle Mexican Grill (CMG) ! ($20 in last three days) I was impatient and
RMPIA
By

Bret Jensen

 | Sep 13, 2016 | 12:00 PM EDT
These stocks look good as seasonal volatility sets in.
RMPIA
By

Jim Cramer

 | Aug 29, 2016 | 6:00 AM EDT
The leadership is quite stark.
RMPIA
By

Doug Kass

 | Aug 24, 2016 | 2:53 PM EDT
The U.S. dollar is stronger. The price of crude oil fell by $1.33 to $46.77. Gold slipped by $17 to $1,329 and appears likely to threaten support at $1,300 to $1,310. Agricultural commodities. wheat -2, corn -1.5, soybean -9, oats flat. Lumber -7 on weak housing data. Bonds are down small. The 10- and 30-year note and bond yields are unchanged. So was the 2s/10s spread (80 basis points). Municipals and junk flat lined, as did Blackstone/GSO Strategic Credit Fund (BGB) and closed-end muni bond funds. Banks remain the world's fair.: Brokerages are holding in well. Same goes for insurance, but my long Hartford Financial Services Group (HIG) is a laggard. Biotech down by about 2%. Allergan (AGN) and Celgene (CELG) are leaders to the downside, with speculative biotech taken to the woodshed, too. Profit-taking continues in retail. Autos are mixed. Energy stocks nonplussed by oil's descent, thus far. Old tech is mixed, but IBM (IBM) is a downside feature. Media is down small. Ag equipment is weaker (I dissed CAT this morning, added to my short) Staples are lower on a stronger currency. In individual stocks, my longs Radian Group (RDN) and DuPont (DD) are doing God's work! Oaktree Capital Group (OAK) is trading better, but it is an odd stock and it's mostly difficult to understand its daily moves. (T)FANG all lower, but not materially. Here are some valuable contributions on our site today: Jim "El Capitan" Cramer on oil and the little guy.  Tim "Not Judy or Phil" Collins sees Babe Ruth -- i.e., Facebook (FB) -- striking out.  Skip Raschke on frowning (and shorting). Rev Shark is waiting for Godot.  Roger Arnold on a rate rise by the Fed (Fischer-style). 
RMPIA
By

Bret Jensen

 | Aug 22, 2016 | 10:31 AM EDT
Las Vegas Sands (LVS) continues to show strength after Bank of America/Merrill Lynch put out an optimistic note this morning about Macau gambling. Energy is weak in early trading. Oil has drifted back down to around $47 a barrel following its recent roughly 20% rally.
RMPIA
By

James Passeri

 | Aug 18, 2016 | 11:55 AM EDT

RBC Capital analysts say splitting the company into two distinct businesses would free 'trapped value' on drug treatments.

RMPIA
By

Bret Jensen

 | Aug 11, 2016 | 12:00 PM EDT
These are the biggest errors that I've made over the years.
RMPIA
By

Bret Jensen

 | Aug 4, 2016 | 12:04 PM EDT
These sectors offer value as the S&P 500 trades at 19x earnings.
On Wednesday of last week NFLX appeared headed for a deep breakdown.  The stock fell ...
We added this one Monday and mentioned it Tuesday right here in CC, we'll take it off the ...
The market is rebounding nicely after yesteday's sell-off.  Biotech has recaptured ha...
The Federal Reserve has made it relatively clear that they intend to raise interest rates...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.